Insider Transactions in Q1 2023 at Harrow Health, Inc. (HROW)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Andrew R. Boll CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
34,442
-9.61%
|
$723,282
$21.16 P/Share
|
|
Mar 31
2023
|
Andrew R. Boll CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
90,000
+20.07%
|
$540,000
$6.0 P/Share
|
|
Jan 02
2023
|
Mark L Baum CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
35,179
-2.31%
|
$492,506
$14.76 P/Share
|
|
Jan 02
2023
|
Mark L Baum CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
88,000
+5.47%
|
-
|
|
Jan 02
2023
|
Andrew R. Boll CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
9,602
-3.45%
|
$134,428
$14.76 P/Share
|
|
Jan 02
2023
|
Andrew R. Boll CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
23,000
+7.64%
|
-
|